STAT3 and osteosarcoma: Previous studies have shown that miR-26b-5p targets methionine adenosyltransferase 2A (MAT2A), leading to reduced GSH levels and promoting ferroptosis by blocking the STAT3/SLC7A11 pathway in osteosarcoma [134].